Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Ovarian Cancer treatment details. Chemotherapy. University of Texas Southwestern Medical Center, Dallas, TX, United States

Survival: 11.4 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Pemetrexed
Country: United States
City/State/Province: Dallas, TX
Hospital: University of Texas Southwestern Medical Center
Journal: Link
Date: 3/2009

Patients: This phase 2 study involved fifty-one women with recurrent or persistent platinum-resistant ovarian or primary peritoneal cancer. The majority were between the ages of 40 and 79.

Treatment: These patients were treated with pemetrexed, a chemotherapy drug.

Toxicity: Grade 4 toxicities included leucopenia, thrombocytopenia, neutropenia, neurological and pain. Other toxicities (grade 3 and milder) included leucopenia, thrombocytopenia, neutropenia, anemia, gastrointestinal, nausea/vomiting, skin changes, neurological, metabolic changes, and infection.

Results: The median overall survival was 11.4 months.

Correspondence: Dr. David Scott Miller

E-mail to a Friend Email Physician More Information